RIVASTIGMINE TARTRATE

Orange BookUNIISPLATC N06DA03

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerNivagen Pharmaceuticals, Inc.

CountryUS (United States)

ATC codeN06DA03

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 2

ndc11
7583413505
500 CAPSULE in 1 BOTTLE, PLASTIC (75834-135-05)
ndc11
7583413560
60 CAPSULE in 1 BOTTLE, PLASTIC (75834-135-60)

Annotations

UNII (FDA Substance ID)

9IY2357JPE

RIVASTIGMINE TARTRATE

RxCUI 994808

Orange Book

A203844

ABABABAB

DailyMed SPL labels

1 version tracked

Raw payload (JSON)

{
  "unii": {
    "unii": "9IY2357JPE",
    "rxcui": "994808",
    "inchikey": "GWHQHAUAXRMMOT-MBANBULQSA-N",
    "display_name": "RIVASTIGMINE TARTRATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "spl_meta": {
    "52781229-ee82-43f9-a113-4419a611978d": {
      "match": "brand_token",
      "title": "RIVASTIGMINE TARTRATE CAPSULE [AMERICAN HEALTH PACKAGING]",
      "spl_version": "2",
      "published_date": "2025-11-21"
    }
  },
  "productid": "75834-135_e272f7d1-d782-4ff1-919c-784c91ee024d",
  "productndc": "75834-135",
  "dosage_form": "CAPSULE",
  "orange_book": {
    "appl_no": "203844",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 1.5MG BASE",
        "product_no": "001",
        "approval_date": "Feb 13, 2017"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 3MG BASE",
        "product_no": "002",
        "approval_date": "Feb 13, 2017"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 4.5MG BASE",
        "product_no": "003",
        "approval_date": "Feb 13, 2017"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 6MG BASE",
        "product_no": "004",
        "approval_date": "Feb 13, 2017"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "RIVASTIGMINE TARTRATE",
  "proprietary_name": "RIVASTIGMINE TARTRATE",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA203844",
  "marketing_category": "ANDA",
  "nonproprietary_name": "RIVASTIGMINE TARTRATE",
  "start_marketing_date": "20170904",
  "active_numerator_strength": "4.5"
}

Related drugs

Other records sharing ATC code N06DA03.

Access this data programmatically

Query RIVASTIGMINE TARTRATE and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs